User contributions
- 14:17, 12 October 2023 (diff | hist) . . (+341) . . Part:BBa K4729703 (→The pVS1 and pBBR1 oris cannot be stably maintained in A. rhizogenes (Cycle 4)) (current)
- 14:06, 12 October 2023 (diff | hist) . . (+1) . . Part:BBa K4729703 (→The pVS1 and pBBR1 oris cannot be stably maintained in A. rhizogenes (Cycle 4))
- 14:05, 12 October 2023 (diff | hist) . . (+384) . . Part:BBa K4729703 (→The pVS1 and pBBR1 oris cannot be stably maintained in A. rhizogenes (Cycle 4))
- 13:47, 12 October 2023 (diff | hist) . . (+346) . . Part:BBa K4729703 (→Sodium Salicylate inhibits cell growth (Cycle 3))
- 13:33, 12 October 2023 (diff | hist) . . (+272) . . Part:BBa K4729703 (→Sodium Salicylate inhibits cell growth (Cycle 3))
- 13:06, 12 October 2023 (diff | hist) . . (+11) . . Part:BBa K4729703 (→Sodium Salicylate inhibits cell growth (Cycle 3))
- 13:05, 12 October 2023 (diff | hist) . . (+399) . . Part:BBa K4729703 (→Sodium Salicylate inhibits cell growth (Cycle 3))
- 12:54, 12 October 2023 (diff | hist) . . (+313) . . Part:BBa K4729703 (→Inducible expression (Cycle 2))
- 12:44, 12 October 2023 (diff | hist) . . (+176) . . Part:BBa K4729703 (→Constitutive expression (Cycle 1))
- 20:04, 11 October 2023 (diff | hist) . . (+668) . . Part:BBa J23102 (→iGEM Marburg 2023 - RhizoGene)